OLEMA PHARMACEUTICALS INC. - COMMON STOCK
5.0400
10-January-25 15:45:00
15 minutes delayed
Stocks
-0.7100
-12.35%
Today's range
4.9350 - 5.6200
ISIN
N/A
Source
NASDAQ
-
Olema Oncology Announces First Clinical Data on OP-1250 in Advanced ER+ / HER2- Breast Cancer
30 Nov 2021 06:00:00 By Nasdaq GlobeNewswire
-
Olema Oncology Issues Statement Regarding Falsified Information Circulating on Social Media
29 Nov 2021 15:27:08 By Nasdaq GlobeNewswire
-
Olema Oncology to Present New Data on OP-1250 at 2021 San Antonio Breast Cancer Symposium
22 Nov 2021 06:30:00 By Nasdaq GlobeNewswire
-
Olema Oncology Reports Third Quarter 2021 Financial Results and Provides Corporate Update
10 Nov 2021 15:05:00 By Nasdaq GlobeNewswire
-
Olema Oncology to Present at Two Upcoming Investor Conferences
09 Nov 2021 06:30:00 By Nasdaq GlobeNewswire
-
30 Sep 2021 16:00:00 By Nasdaq GlobeNewswire
-
09 Sep 2021 06:30:00 By Nasdaq GlobeNewswire
-
Olema Oncology to Present at Morgan Stanley 19th Annual Global Healthcare Conference
30 Aug 2021 15:05:00 By Nasdaq GlobeNewswire
-
Olema Oncology Reports Second Quarter 2021 Financial Results and Provides Corporate Update
10 Aug 2021 15:05:01 By Nasdaq GlobeNewswire
-
Olema Oncology to Participate at the Jefferies 2021 Virtual Healthcare Conference
18 May 2021 15:05:00 By Nasdaq GlobeNewswire
-
Olema Oncology Reports First Quarter 2021 Financial Results and Provides Corporate Update
11 May 2021 15:05:01 By Nasdaq GlobeNewswire
-
Olema Oncology to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference
07 Apr 2021 06:30:00 By Nasdaq GlobeNewswire
-
Olema Oncology Appoints Oncology Biotech Executive Yi Larson, MBA, to Board of Directors
06 Apr 2021 06:30:00 By Nasdaq GlobeNewswire
-
17 Mar 2021 15:05:00 By Nasdaq GlobeNewswire
-
10 Mar 2021 15:45:00 By Nasdaq GlobeNewswire
-
Olema Oncology to Participate at Upcoming Virtual Investor Conferences
23 Feb 2021 06:00:01 By Nasdaq GlobeNewswire